Extraordinary shareholders’ meeting

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, are hereby given notice to attend an extraordinary shareholders’ meeting to be held at the company’s premises on Västra Trädgårdsgatan 15 in Stockholm, Sweden, on Monday, 6 February 2017 at 9:00 a.m. (CET).

Annual General Meeting 2017

Oncopeptides Annual General Meeting to be held in the Banquet room at IVA Conference center, Grev Turegatan 16, Stockholm, Sweden, Thursday 18 May 2017 at 4.00 p.m.

ASH 2017 Summary webcast

Oncopeptides has a press conference at 14.30 CET, December 13. To attend, please call the following numbers: UK: +442030089801 SE: +46856642662 US: +18557532235 The conference call will also be streamed...